https://www.accesswire.com/543034/Dyadic-to-Report-First-Quarter-2019-Financial-Results-on-Thursday-May-9-2019

JUPITER, FL / ACCESSWIRE / April 25, 2019 / Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development, lower production costs and improve the performance of biologic vaccines, drugs, and other biologic products at flexible commercial scales, today announced that it will report its financial results for quarter ended March 31, 2019 after the market close on Thursday, May 9, 2019 and it will host a conference call that day at 5:00 p.m. Eastern Time to discuss those results.

Dial-in numbers: (877) 407-8033 (U.S. or Canada) or +(201) 689-8033 (International)